Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
WuXi, 926281-37-0
319 Advanced technologies, such as motion capture systems and wearable sensors, provide real-time data on movement mechanics and biomechanical stresses
Common community observation pattern Anecdotal only
Someone wanting minor cosmetic changes smoothing a bump, lifting the tip, improving symmetry without surgery
Long-Acting Amylin Agonist GUB014295 Gubra A/S (Hrsholm, Denmark), a biotech company specialized in pre-clinical contract research, initiated a phase 1 clinical trial (NCT06144684) to investigate the safety, tolerability and pharmacological properties of GUB014295 (GUBamy), a long-acting OW SC amylin agonist, in healthy volunteers [117]
As always, this is educational contentnot medical advice
